|
JAK2 Inhibition to Treat Platinum Resistant Ovarian Cancer
Researchers at GW overcame platinum drug resistance in ovarian cancer by combining JAK2 inhibitor LY2784544 with standard platinum based chemotherapeutics. Doctors commonly prescribe platinum-based drugs, like cisplatin, to treat ovarian cancer. Over time many patients become resistant to the treatment and succumb to the disease. Doctors need new options...
Published: 1/7/2022
|
Updated: 10/26/2021
|
Inventor(s): Wenge Zhu, Wei Zhou, Wei Zheng, Wei Sun
Keywords(s):
Category(s): Technology Classifications > Therapeutics > Small Molecules
|
